Skip to main content
SpringerLink
Log in

Lurasidone was determined to be ’safe’ and generally well tolerated across five placebo-controlled trials

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Cucchiaro J, Pikalov A, Ogasa M, Silva R, Hsu J, Xu J, Loebel A.Safety of lurasidone: Pooled analysis of five placebo-controlled trials in patients with schizophrenia. 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum: abstr. 021, 6 Jun 2010. Available from: URL: http://www.cinp2010.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lurasidone was determined to be ’safe’ and generally well tolerated across five placebo-controlled trials. React. Wkly. 1307, 8 (2010). https://doi.org/10.2165/00128415-201013070-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013070-00019

Keywords

Search

Navigation